Biotech VC Funds

HealthCap, founded in 1996 and headquartered in Stockholm, is a European venture capital firm focused on life sciences. The firm invests globally in companies developing breakthrough therapies that address unmet medical needs, particularly in areas like rare diseases, oncology, and genetic disorders. Over the years, HealthCap has backed more than 127 companies, resulting in over 30 approved pharmaceutical products and 50 medical devices, making it one of the largest specialized life sciences investors in Europe. The firm has raised eight funds to date, with over €1 billion in committed capital. HealthCap's portfolio boasts impressive exits, including companies like OxThera and Aprea Therapeutics, and more than 47 of its portfolio companies have gone public. The firm takes an active role in its investments, with partners frequently joining the boards of portfolio companies, guiding them through clinical trials and regulatory processes. HealthCap’s investment strategy emphasizes precision medicine, targeting innovative therapies that improve patient outcomes. With a strong track record of fostering startups into market leaders, the firm plays a crucial role in shaping the future of healthcare.

HealthCare Ventures is a life science-focused venture capital firm founded in 1985 and headquartered at 47 Thorndike Street in Cambridge, Massachusetts. Over more than 35 years, the firm has invested $1.6 billion in more than 100 therapeutic, diagnostic, device, and healthcare technology companies, establishing itself as one of the longest-running healthcare-dedicated VC firms in the United States. Harold Werner serves as Managing Director, and the firm employs approximately 11 people. HealthCare Ventures focuses specifically on pre-clinical or early clinical stage companies with transformative potential in patient care, deploying check sizes in the $3 million to $10 million range across Seed, Series A, and Series B rounds and leading rounds. The firm has made at least 32 tracked investments according to public databases. Portfolio sectors span therapeutics, diagnostics, medical devices, and healthcare technology. A recent notable portfolio exit was Paige, an AI-powered cancer diagnostics company, which exited on August 22, 2025. HealthCare Ventures takes a hands-on approach that goes beyond providing capital: the team actively helps manage portfolio companies, providing operational guidance, strategic input, and scientific expertise throughout the development journey from pre-clinical work to commercialization. The firm's nearly four decades of continuous operation in life science venture investing give it institutional knowledge and relationships across the clinical, regulatory, and commercial ecosystem that span multiple full innovation cycles in biotechnology and medical devices.

HealthQuad is India's leading healthcare-focused venture capital fund, co-founded by Quadria Capital in 2016. The firm targets early-stage investments in companies that are poised to transform the healthcare sector through technological innovation and improved accessibility. HealthQuad's mission is to enhance healthcare affordability, accessibility, and quality in India. The fund recently closed its second fund, HealthQuad Fund-II, raising $162 million, more than double its initial target. This fund focuses on investing in companies that digitize the healthcare value chain, addressing significant gaps revealed during the COVID-19 pandemic, such as the surge in teleconsultations and e-pharmacy usage. HealthQuad's portfolio includes innovative companies like Medikabazaar, THB, HealthifyMe, and ImpactGuru. These investments highlight the fund's commitment to supporting digital health platforms and integrated healthcare financing solutions​. The fund plans to invest in 12-14 companies with individual cheque sizes ranging from $5 to $20 million. Led by co-founders Abrar Mir, Amit Varma, and Charles-Antoine Janssen, HealthQuad leverages extensive industry experience and a robust network to guide its portfolio companies through growth and innovation in the healthcare sector.

HealthQuest Capital, established in 2012 and headquartered in Redwood City, California, is a private asset firm dedicated to providing growth capital to transformative healthcare companies. Their investment focus spans medical devices, diagnostics, digital health, healthcare IT, and innovative services. They prioritize commercial-stage companies that demonstrate proven products or services and require resources to scale effectively. HealthQuest typically invests between $20 million and $100 million per company, often leading the investments and syndicating when necessary. The firm is committed to enhancing patient outcomes and healthcare delivery efficiency, managing approximately $2 billion in assets. The leadership team, spearheaded by founder Garheng Kong, consists of experienced professionals with a combined 300+ years in healthcare investing and operations. Key team members include Randy Scott, Sam Brasch, Sharath Reddy, and Conrad Wang. The firm also boasts a distinguished Board of Advisors featuring notable industry leaders like Regina Benjamin, former U.S. Surgeon General, and Bruce Broussard, CEO of Humana. HealthQuest's portfolio includes companies like Alcresta Therapeutics, Everlywell, Inbound Health, Pulmonx, and TigerConnect. They actively seek investments that offer innovative healthcare solutions and possess the potential for significant growth and impact.

Heda Ventures is a venture capital firm established in 2008 with headquarters in San Jose, California, and additional operations in Hangzhou, China. The firm specializes in early-stage investments in cutting-edge industries, particularly focusing on biotechnology, healthcare, and the technology, media, and telecommunications (TMT) sectors. Heda Ventures has built a robust portfolio of over 67 investments, working closely with startups that are driving innovation in areas such as diagnostic equipment, drug discovery, semiconductors, and medical supplies. The firm is known for its strategic approach to investment, aiming to support companies with high growth potential by providing not just capital but also guidance and access to its extensive global network. This approach helps portfolio companies scale effectively and achieve market success. Heda Ventures has also been involved in significant exits, including companies like Just - Evotec Biologics and DeepMap, which highlight its successful track record in the venture capital space. With a deep commitment to fostering innovation, Heda Ventures continues to focus on transformative technologies that address critical challenges in healthcare and technology, positioning itself as a key player in the venture capital landscape. The firm's ability to bridge the gap between the U.S. and Chinese markets further enhances its capability to nurture and grow companies on a global scale.

Helicase Venture is an early-stage life sciences venture capital firm founded in 2018 and headquartered in Boston with an additional presence in San Francisco. The firm focuses on innovative life sciences and Bio-IT companies — businesses at the intersection of engineering, health, and AI — with a mission to work alongside early-stage teams as they navigate developmental milestones and bring therapies to patients. The two-partner team is led by Dr. Richard Tsai, a Founding Member who previously served as a Partner at BioEngine Capital where he headed life science investments and was involved in founding multiple companies, and Dr. Joy Lee as Partner. The firm leads rounds and targets Seed and Series A investments with initial commitments of $1 to $5 million. Helicase manages one fund, Helicase Venture Fund I, which has backed eight companies across the United States, Austria, and China, producing two IPOs and three acquisitions. Notable portfolio companies include AbSci (AI-driven drug and target discovery using deep learning and synthetic biology, which completed a Nasdaq IPO in July 2021 at a $1.45 billion market capitalization), Tangible Science (contact lens technology spanning consumer to smart applications), and Totient (AI-driven biotech leveraging tertiary lymphoid structures for novel tissue-specific antigens and high-affinity antibody therapeutics, which was subsequently acquired by AbSci). Helicase makes investment decisions as a team, with each partner contributing domain expertise across biological sciences and computational technologies, supplemented by a network of scientific advisors. The firm's focus on companies working at the frontier of biology and computation reflects a thesis that the most transformative near-term progress in patient care will come from founders who can move fluidly between wet lab science and data-driven discovery.

Hemi Ventures is an early-stage venture capital firm headquartered in San Francisco, focused on investing in transformative technologies that shape the future. Their portfolio boasts notable investments in companies such as Plus.ai, a leader in autonomous trucking technology, and Ample, which revolutionizes electric vehicle battery swapping. Hemi Ventures targets industries including autonomous vehicles, artificial intelligence, biotechnology, and advanced manufacturing, providing critical support to startups at the cutting edge of innovation. The firm's investment strategy centers on seed and Series A funding rounds, typically leading these rounds with substantial financial backing and strategic guidance. With an average check size around $3 million, Hemi Ventures actively partners with entrepreneurs to ensure growth and success. They emphasize a hands-on approach, offering not just capital but also access to their extensive network and expertise in scaling businesses. Key figures at Hemi Ventures include founder and managing partner Amy Gu, who brings a wealth of experience in both the tech industry and venture capital. The firm’s leadership is deeply involved in fostering innovation and supporting startups through every stage of their development. For startups seeking investment, Hemi Ventures values groundbreaking ideas with clear market potential and strong technological foundations. Approaching them with a well-defined vision and a robust plan for growth is essential. They prefer to engage with companies that have the potential to redefine industries and drive substantial advancements in their respective fields.

Hemisphere Ventures is a venture capital firm based in Mercer Island, Washington, that focuses on pre-seed and seed-stage investments in cutting-edge technologies. Founded in 2014, the firm primarily invests in sectors like software, biotech, space tech, robotics, drones, and nanotechnology. Their portfolio includes companies like PlanetiQ, Axiom, and Finless Foods, which are leading advancements in space exploration, synthetic biology, and sustainable food production. Hemisphere Ventures actively seeks out companies that are pushing the boundaries of science and technology, often in niche but high-potential areas like space travel, advanced AI, and biotech innovations. They aim to provide not just capital but strategic guidance to help startups scale rapidly. The firm is known for supporting companies that have strong potential to reshape industries and create long-term societal impact. The team at Hemisphere Ventures consists of experienced founders, operators, and investors, who bring decades of expertise in building and scaling businesses across various industries. Their investments reflect a deep interest in transformative technologies with a global reach, helping startups grow at an unprecedented pace.

Henkel Ventures is the corporate venture capital arm of Henkel AG & Co. KGaA, the German multinational whose brands include Loctite, Schwarzkopf, and Persil. Founded in 2016 and headquartered in Dusseldorf, the fund manages €300 million in assets under management and invests between €0.5 million and €5 million per deal, targeting startups from Seed through Series B. Henkel Ventures leads rounds and collaborates closely with Henkel's two business units — Henkel Consumer Brands and Henkel Adhesive Technologies — to co-develop innovations and create commercial pathways for portfolio companies. The fund is geographically agnostic and provides startups with access to over 3,000 Henkel R&D experts. The fund's thematic focus spans Sustainovation (sustainability-driven innovation) and Digitalization, expressed through investments in climate tech, deep tech, commerce and MarTech, enterprise tech, and longevity. The active portfolio of approximately 24 companies includes Aether Bio (enzyme engineering, Henkel's most recent investment in December 2025), eeden (textile recycling, €18 million Series A in 2025), Actnano (nanotechnology for water damage protection), Copprint (copper nanoparticle conductive inks), CleanHub (ocean plastic recovery), Fero Labs (manufacturing optimization AI), ResearchGate (scientific network), Streetbees (AI consumer insights), LoveLocal (digital retail in India), and Software Defined Automation (industrial automation). Previous exits include ZipJet and NBD Nanotechnology, both acquired. The portfolio totals 27 tracked investments. Henkel Ventures creates a two-way value exchange: portfolio companies gain access to Henkel's global manufacturing, commercial, and scientific resources, while Henkel gains early exposure to technologies that could reshape its core adhesives and consumer brands businesses. Arianna Savini from the team received the Rising Stars 2024 award from Global Venturing.

Heran Partners, founded in 2020 and based in Antwerp, Belgium, is a venture capital firm focusing on MedTech and HealthTech ventures. Their mission is to fuel the growth of innovative technologies at the intersection of life sciences and data. They support startups and scale-ups that develop disruptive innovations ranging from medical devices to AI solutions for diagnostics and patient monitoring. Heran Partners has a strategic investment approach, targeting key drivers in healthcare such as the need for insightful data, cost-effective solutions, and personalized medicine. The fund typically invests up to EUR 5 million in early-stage companies, offering not only financial support but also strategic guidance, scientific expertise, and a strong network to maximize the ventures' potential. Notable investments include companies like Icometrix, which uses AI to quantify brain structures from MR and CT scans, and Hypervision Surgical, an advanced surgical imaging and data analytics platform. The fund has also seen successful exits, including BlueBee and PharmaFluidics. The team is led by experienced professionals like Annie Vereecken, a serial life sciences entrepreneur, Katleen Vandersmissen, Herman Verrelst, and Joris Mortelmans. They emphasize building long-term relationships with their portfolio companies, growing hand-in-hand with founders and management teams. Heran Partners actively co-invests with other venture capital firms to leverage complementary skills and networks, positioning themselves as a key player in the European HealthTech investment landscape​.

Heritas Capital is a Singapore-based private equity and venture capital firm that focuses on high-growth sectors such as healthcare, education, and technology. Established in 1997, the firm has evolved into a key player in impact investing, driven by its philosophy of “Invest with Purpose, Impact Across Generations.” The firm manages a diverse portfolio of investments, backing companies that aim to create positive social and environmental change while delivering sustainable financial returns. Heritas Capital actively supports ventures across Asia through a multi-stage investment platform, targeting seed to growth stages. It has been involved in significant funding rounds for companies like Holmusk, Hummingbird Bioscience, and Cakap, addressing needs in areas such as digital health, biotech, and edtech. The firm also partners with organizations like SEEDS Capital to co-invest in promising startups, helping scale impact-focused innovations. Heritas Capital’s approach includes a strong commitment to improving access to healthcare and lifelong learning while leveraging technology to drive efficiencies in industries like foodtech and urban solutions. By aligning with partners who share their vision, Heritas ensures that their investments have a long-lasting, generational impact.

Heuristic Capital Partners is an early-stage venture capital firm based in Santa Clara, California. Established in 2016, the firm focuses on investments in hardware-centric startups, especially within the health tech, robotics, medtech, and consumer electronics sectors. The firm aims to support companies through critical stages such as prototyping, financing, manufacturing, and scaling up their businesses. Heuristic Capital Partners has made 46 investments, with notable exits including companies like Lucira Health and LARQ. They provide a hands-on approach, leveraging over 25 years of professional and personal venture investment experience from their three managing directors: Michael Liao, Ren Du MD, and Shu Cao. This team brings a wealth of experience from startup challenges to IPOs and mergers. Their investment strategy is rooted in practical problem-solving and creativity, aiming to help startups overcome hurdles and achieve growth. The firm has raised $34 million for their first venture fund, emphasizing their commitment to supporting early-stage hardware innovations​.

Highbury Group is an early-stage venture capital firm, founded by Dr. Ling Wong and based in Seattle, Washington. Established in 2014, the firm specializes in investments within the healthcare, biotechnology, digital health, and AI sectors. With a deep focus on transformative technologies, Highbury Group supports innovative companies working in diagnostics, healthcare technology, and AI-driven solutions. The firm seeks out companies at the seed and Series A stages, with typical investments ranging from $500,000 to $50 million, targeting a sweet spot of around $10 million. The firm has built a strong reputation through strategic investments in industry leaders like Notion, ScienceIO, and Spring Discovery, positioning itself at the forefront of the healthcare and biotech spaces. Highbury Group has seen several notable exits, including Guardant Health’s IPO and the acquisition of companies like Edify and Scanwell Health. Dr. Ling Wong brings extensive experience as both an operator and investor, with a proven track record of accelerating growth for portfolio companies. The firm’s investments focus on solving critical healthcare challenges through innovation, aiming to back companies that have the potential to make a significant impact on health outcomes globally. Highbury Group's unique investment strategy combines deep sector expertise with a commitment to supporting early-stage startups through their most critical phases of development. The firm’s approach ensures it plays a pivotal role in shaping the future of healthcare technology and AI​.

Hellman & Friedman (H&F) is a prominent private equity firm with a long history of making large-scale investments in high-quality growth businesses. Founded in 1984, the firm is headquartered in San Francisco, with additional offices in New York and London. H&F focuses on a concentrated investment strategy, deploying significant capital in a limited number of sectors where it has deep expertise, such as software and technology, financial services, healthcare, consumer and retail, and other business services​. The firm recently closed its tenth fund, Hellman & Friedman Capital Partners X (HFCP X), with commitments totaling $24.4 billion, making it one of the largest private equity funds ever raised. This fund will enable H&F to continue its strategy of targeting large-scale investments in outstanding growth businesses, primarily in North America and Europe. H&F is known for its collaborative approach, working closely with management teams to develop and implement value creation plans tailored to each company's specific needs. The firm prides itself on its long-term investment horizon and alignment of interests with its portfolio companies, fostering a culture of mutual success.

Hike Ventures is a venture capital fund specializing in artificial intelligence and machine learning. Founded by seasoned professionals in San Francisco, Tokyo, and Toronto, Hike Ventures focuses on early-stage investments in startups that leverage AI to solve well-defined problems in innovative ways. Their notable investments include companies like Beatdapp, Botpress, CalmWave, and Greeneye, which are driving advancements in sectors ranging from media and entertainment to healthcare and agriculture. The fund primarily invests in North America and Japan, supporting startups that bring transformative AI solutions to market. Their strategy involves not just capital investment but also providing strategic support to help startups scale effectively. Hike Ventures typically invests in seed-stage rounds, offering checks that allow startups to accelerate their growth while benefiting from the fund's deep expertise in AI and machine learning. Key team members include Mikihiro Yasuda, based in San Francisco, who has a robust background in tech leadership and venture investment, and Taka Shoji, based in Tokyo, who has extensive experience in startup incubation and international investment. Both partners bring a wealth of experience from their previous roles in companies like Digital Garage, Netscape, and Baidu Japan. Hike Ventures is proactive in its engagement with startups, often leading rounds and providing hands-on guidance. They value approaches that combine algorithmic innovation with human insight, seeking out startups that can navigate complex AI challenges with practical, scalable solutions.

Hillhouse Investment Group is a leading global investment firm, founded in 2005 by Zhang Lei. Based in Hong Kong with additional offices in Beijing, Hillhouse focuses on long-term investments across public and private markets. The firm’s strategy revolves around building sustainable, high-quality businesses, with particular emphasis on healthcare, consumer, industrials, and technology sectors. Initially starting with a $20 million investment from Yale University's endowment fund, Hillhouse has grown into a financial giant managing over $60 billion in assets. Known for its rigorous research and hands-on approach, the firm partners with management teams to drive innovation and growth in its portfolio companies. Notable investments include major players like Tencent, Zoom, and JD.com. Hillhouse is also active in private equity and venture capital, making significant contributions to early and growth-stage companies across Asia, North America, and Europe. Its venture arm, GL Ventures, supports early-stage technology and healthcare startups. The firm is recognized for its ability to anticipate market trends and build long-term value in companies that can withstand evolving economic landscapes. With a reputation for aligning closely with management teams and maintaining a disciplined investment strategy, Hillhouse continues to be a powerful force in global markets.

Hiroshima Venture Capital Co., Ltd. (H-VC) is a Japanese venture capital firm founded in 1995 and headquartered in Hiroshima, Japan. The firm provides investment and financing, market research, and business support services to small and medium-sized companies with high growth potential, and has built a track record of 119 investments over three decades. With 14 portfolio IPOs and over 4 acquisitions, H-VC is one of the more productive regional venture capital firms in Japan in terms of exit volume. The firm invests across pre-seed through Series B stages with checks typically ranging from $100,000 to $3 million, covering software, health technology, biotech, e-commerce, and AI sectors. Recent IPO exits include Laxus, which listed on the Tokyo Stock Exchange in December 2024 with a $34.9 million market cap, and D&M Company, which also listed on the TSE. Notable exits include Future Standard, acquired by DENSO Corporation in December 2024. Recent investments include Light Touch Technology (February 2026), Olive (January 2026, co-invested with Aichi Capital, Canon MJ MIRAI Fund, and Ignition Point Venture Partners), and Smooth ($10.18 million Series B, December 2025). Other active portfolio companies include SPACER, INDUSTRIALX, KOMPEITO, Integriculture (a cell-based food startup), and Ababa. H-VC co-invests extensively with Japan's regional and institutional VC community, partnering with firms such as SMBC Venture Capital, Mitsubishi UFJ Capital, and CyberAgent Capital. With a small team of three members, the firm maintains a concentrated, high-conviction investment style with deep ties to the Hiroshima and broader western Japan startup ecosystem.

Hiventures, a Hungarian state-owned venture capital fund, is renowned for its extensive portfolio and dynamic investment strategy. With a focus on supporting startups from pre-seed to growth stages, Hiventures has made over 770 investments across various sectors, including software services, cloud computing, and cybersecurity. Notable investments include Access4you, iBar Experience, and Surviot Monitoring, showcasing their commitment to innovation in diverse industries. Geographically, Hiventures primarily invests within Hungary, emphasizing the growth of the local entrepreneurial ecosystem. Their strategy involves flexible investment conditions and a quick adaptation to the needs of startups, making them a preferred partner for early-stage ventures. Hiventures typically invests around $983,000 per round, actively leading many of these investments. They maintain a high engagement level, with an average of 30.96 rounds per year, peaking in 2021. The fund's team, including key figures like CEO Eszter Jandrasics and Senior Investment Manager Ádám Horváth, brings deep expertise in venture capital and business development. For startups looking to approach Hiventures, it's beneficial to highlight innovative solutions and scalability. They prefer well-prepared pitches that align with their focus on fostering technological advancements and economic growth in Hungary.

Hong Kong Science and Technology Parks Corporation (HKSTP) is the leading innovation and technology (I&T) ecosystem in Hong Kong. Established in 2001, HKSTP fosters tech startups and industry growth, focusing on sectors like healthtech, AI and robotics, fintech, and smart city innovations. The corporation manages a network that includes the Hong Kong Science Park, InnoCentre, and InnoParks, supporting over 1,700 companies and 14,000 R&D professionals. HKSTP offers full-cycle support to startups, from incubation and prototyping to funding and commercialization. They manage the HKSTP Venture Fund, a HK$1 billion asset fund, to support high-growth tech ventures, and have groomed multiple unicorns within their ecosystem. With strong connections to the Greater Bay Area, HKSTP also helps companies expand into mainland China. Their resources include world-class R&D labs, co-working spaces, advanced manufacturing centers, and a broad investor network. HKSTP’s mission is to drive collaboration, accelerate innovation, and cultivate talent for Hong Kong and the broader region, positioning the city as a leading global innovation hub.

HLM Venture Partners is a leading venture capital firm focused exclusively on healthcare technology and services. Based in Waltham, Massachusetts, the firm has been at the forefront of healthcare investment for over 40 years, deploying more than $400 million across 100+ companies. HLM targets companies that are capital-efficient and patient-centric, helping them scale by offering not just financial support, but strategic guidance and deep industry expertise. The firm focuses on key healthcare sectors like healthcare IT, value-based care, medical devices, and patient engagement. HLM is particularly interested in companies addressing critical issues like expanding access to care, behavioral health innovations, and solutions for provider shortages. Notable investments include Teladoc, a pioneer in telemedicine, NeuroFlow, which leverages AI for mental health support, and mPulse Mobile, a leader in mobile patient engagement solutions​. HLM prides itself on being a first-call partner for its portfolio companies, providing hands-on support to help them navigate complex regulatory landscapes and reach their growth potential. Their extensive healthcare network gives their startups unrivaled access to key decision-makers across the care continuum. Over the years, HLM has created significant value for both its portfolio companies and investors, facilitating the growth of several iconic healthcare brands. By aligning themselves with bold, principled management teams, HLM continues to drive transformative healthcare solutions that improve both quality and cost of car.

HOF Capital is a global venture capital firm headquartered in New York, focused on investing in transformative technology companies from idea to IPO. With support from over 70 influential family offices, global corporations, and institutions, HOF provides startups with more than just capital—they offer strategic partnerships that open doors to new markets, customer bases, and operational growth. Their portfolio features industry-leading companies such as Alibaba, Epic Games, UiPath, and ASAPP. HOF Capital specializes in sectors like fintech, deep tech, healthcare, and logistics, making investments from pre-seed to late-stage rounds. The firm’s approach emphasizes long-term value creation, guiding entrepreneurs through various growth stages with business development, sales, and fundraising support. With offices in New York, London, and San Francisco, and a team of investors spread across key global regions, HOF operates as a bridge between startups and large-scale enterprises. Co-founded by Hisham Elhaddad, Onsi Sawiris, and Fady Yacoub, HOF leverages its vast network of partners, including industry giants like Visa, Nvidia, and Daimler, to provide startups with critical resources and strategic advice. Their multi-stage investment strategy, combined with deep industry knowledge and a vast network, helps startups scale quickly while navigating complex challenges in highly competitive environments.

Hokkaido Venture Capital (HVC) is a Japanese venture capital firm founded in 1999 and headquartered in Sapporo, Hokkaido. The firm manages 12 funds and operates with a team of 9 people including 5 partners. Beyond investing, HVC provides management consulting, startup support, M&A advisory, IPO preparation, business succession, and restructuring services to portfolio companies, functioning as a full-service growth partner for emerging Japanese businesses. HVC focuses on seed and Series A investments in Japan-based startups with checks typically ranging from $500,000 to $3 million. The firm has made 49 investments over its history, with life sciences and high tech representing the strongest sector concentrations. The portfolio has produced 12 IPOs, including AnGes, RACCOON HOLDINGS, and Immuno-Biological Laboratories. The most recent investment was in Mechano Cross (September 2025, co-invested with Angel Bridge, Incubate Fund, and Mitsubishi UFJ Capital) and Sagri ($6.84 million Series A in August 2024, an agritech and environmental services company backed alongside Global Brain, Globis Capital Partners, and Kirin Holdings). The firm also made a follow-on into KitchHike in April 2025. HVC co-invests extensively with Japan's regional and institutional VC community, frequently partnering with SMBC Venture Capital, Mitsubishi UFJ Capital, and peer regional funds. This collaborative style gives portfolio companies access to a broader network of industry relationships and follow-on capital pathways. Atmark Techno, acquired by COREStaff in June 2016, represents one recorded acquisition exit.

Homebrew is a unique venture capital fund dedicated to early-stage investments, founded by Hunter Walk and Satya Patel. With a focus on seed-stage startups, Homebrew partners with mission-driven founders to build transformative companies. They have a notable portfolio including companies like Plaid, Mercury, and Winnie, reflecting their commitment to impactful ventures. Primarily investing in software and technology sectors, Homebrew targets industries like fintech, AI, robotics, and healthcare. Their geographic focus is predominantly in North America, supporting startups across the U.S. and Canada. Homebrew's investment strategy emphasizes a hands-on approach. They typically lead or co-lead seed rounds, with initial investments ranging from $250k to $800k. Homebrew is known for their deep involvement with portfolio companies, offering not just capital but also strategic counsel, operational support, and access to their extensive network. Recently, Homebrew transitioned to an evergreen investment model, utilizing their own capital to maintain flexibility and alignment with founders' needs. This shift allows them to engage with startups at various stages without being constrained by traditional fund structures. The team at Homebrew includes industry veterans like Hunter Walk and Satya Patel, both former Google product executives. They are based in Burlingame, California, and are recognized for their commitment to fostering strong, supportive relationships with entrepreneurs.

Honeywell is a global technology and manufacturing leader, delivering a diverse range of products and services across various sectors. In aerospace, Honeywell provides advanced avionics, propulsion, and aircraft management systems, enhancing safety and efficiency for commercial and defense aircraft. Their building technologies division offers smart solutions for energy efficiency, security, and automation, contributing to more sustainable and connected buildings. In the realm of performance materials and technologies, Honeywell develops high-performance chemicals, materials, and industrial software, supporting a wide array of industries from oil and gas to pharmaceuticals. The safety and productivity solutions division focuses on providing innovative safety equipment, advanced software, and workflow automation technologies that boost operational efficiency and worker safety. Honeywell is deeply committed to sustainability, integrating environmental considerations into their product development and operational strategies. They aim to reduce their carbon footprint and help customers achieve their sustainability goals through cutting-edge technologies and solutions. Through continuous innovation, strategic partnerships, and a strong emphasis on quality and reliability, Honeywell strives to drive progress and create value for customers worldwide, shaping a more efficient, safe, and sustainable future.

Horizons Ventures is a Hong Kong-based venture capital firm and single-family office co-founded in 2002 by Solina Chau and Debbie Chang, with billionaire Li Ka-shing joining as principal backer in 2004. The firm focuses on investing in deep science and technology with the potential to propel humanity toward a radically better future, and has deployed over $420 million across 208 companies over more than two decades, averaging 12 new investments annually over the past decade. Check sizes typically range from $500,000 to $10 million, with investments reaching up to $20 million. Horizons Ventures leads rounds and backs companies across deep science and biotechnology, healthcare technology, sustainable technology, food and agriculture, and AI and fintech. The portfolio includes some of the most consequential technology companies of the past two decades: early investments in Facebook, Skype, Siri (acquired by Apple), Waze (acquired by Google), and Summly (acquired by Yahoo). Current unicorn holdings include Zoom and Spotify. Impossible Foods (alternative proteins) and Notpla (sustainable packaging, which raised GBP 20 million in September 2024) represent the firm's sustainable technology focus. Recent investments include Alpaca (Series D, January 2026) and Owlstone Medical ($27 million Series E, January 2025). The firm invests globally with a predominant focus on US companies, supplemented by investments in Australia, Hong Kong, Indonesia, and Israel. Horizons Ventures is widely recognized for identifying transformative companies at early stages well before mainstream investor consensus, a philosophy anchored in Li Ka-shing's long-horizon conviction in fundamental scientific and technological breakthroughs.

Hotung Venture Group is Taiwan's largest venture capital management group by assets under management, incorporated in 1987 and headquartered in Taipei. The holdings company, Hotung Investment Holdings Limited, has been listed on the Singapore Exchange since 1997 (SGX: BLS), making it the first and only Taiwan venture capital firm to list on the SGX. The group operates two business segments — venture capital and fund management — with investment coverage spanning Taiwan, China, and Silicon Valley. The team averages 19 years of accumulated investment expertise. Over more than 30 years of operation, Hotung has invested in over 700 companies with a total portfolio value exceeding $5 billion. More than 200 portfolio companies have been successfully acquired or listed on major stock exchanges including the TWSE, HKEX, NEEQ, NASDAQ/NYSE, and AIM/OFEX. The firm invests in companies at start-up and expansion stages across e-commerce, manufacturing, healthcare, biotech, agricultural innovation, AI, IoT, cloud services, and 5G. Known portfolio companies include Rivos, Indie Microelectronics, iKala, and Vancl, which achieved unicorn status in 2011. The firm has a team of 14 investment professionals. Hotung's approach centers on identifying technologies and innovations that meet underlying societal needs, with a long-duration holding philosophy shaped by decades of experience across multiple technology cycles. The combination of deep regional expertise, a public market track record on the SGX, and a portfolio breadth spanning early-stage startups to exchange-listed companies gives Hotung a distinctive position among Asian venture capital institutions.

Hoxton Ventures is a London-based early-stage venture capital firm known for backing some of Europe’s most successful startups, including Deliveroo, Babylon Health, and Darktrace. Founded in 2013, Hoxton focuses on investing in disruptive technology companies with the potential to become global leaders in their sectors. The firm primarily targets startups at the pre-seed and seed stages, helping them scale with both financial support and strategic guidance. Hoxton Ventures has a strong track record of identifying innovative companies across diverse industries such as fintech, healthcare, AI, and enterprise software. Their portfolio includes notable investments that have either gone public or reached unicorn status. The firm operates as a partner-only team, ensuring that founders receive direct attention and mentorship from experienced investors who have backgrounds in building and scaling companies themselves. With a proactive approach, Hoxton leverages deep industry expertise and a global network to support the growth of its portfolio companies. The firm typically invests above €3 million and provides operational support to help startups navigate their early stages, positioning them for long-term success in the competitive European startup ecosystem.

High-Tech Gründerfonds (HTGF) is a prominent seed investor based in Bonn, Germany, focused on supporting innovative technology startups in fields such as digital technology, industrial tech, life sciences, and chemistry. Established in 2005, HTGF has invested in over 750 startups and manages more than €2 billion across multiple funds. The firm is a key player in the European venture capital scene, specializing in early-stage investments and follow-on financing. HTGF's approach involves providing more than just capital; they actively assist startups through their vast network, supporting business growth, customer acquisition, and strategic partnerships. The typical investment size starts at €800,000 for seed rounds, with potential follow-on investments of up to €4 million per startup over the company's lifecycle. HTGF has been instrumental in facilitating exits, with over 180 successful exits to date, including IPOs. With the launch of their fourth fund in 2023, HTGF raised nearly €500 million, marking it as their largest fund yet. The firm supports startups not only in Germany but across Europe, as long as they maintain a German presence, helping young companies scale and thrive on the global stage.

Human Capital is a unique venture capital firm based in San Francisco that combines traditional VC investing with a strong focus on talent acquisition and organizational development. Founded by Armaan Ali and Chris Zhang, the firm has a multi-stage investment strategy that spans from seed to growth stages, with a mission to support ambitious founders in building transformative companies. Human Capital has a diverse portfolio, investing in high-potential startups across various sectors, including technology, healthcare, and fintech. Some notable investments include Snowflake, Brex, Livongo, Anduril, and Applied Intuition. The firm emphasizes partnering with founders to build strong teams and scalable businesses, leveraging its extensive network and expertise in recruitment to help companies grow from inception to maturity​/ The firm's approach involves not just capital investment but also providing hands-on support in talent management. They assist portfolio companies in attracting, hiring, and retaining top talent, ensuring that the startups have the human capital necessary to succeed in highly competitive markets​.

Human Ventures is an early-stage venture fund and startup studio based in New York City. They focus on investing in companies that address fundamental human needs across various sectors, such as health and wellness, the future of work and money, and media and attention. Founded on the principle of "human first," Human Ventures supports founders who are passionate about creating products and services that have a meaningful impact on society. The firm is led by a diverse team of experienced professionals, including General Partner and CEO Heather Hartnett, Executive Chairman Joe Marchese, and General Partner and COO Michael Letta. They emphasize values such as growth, resilience, collaboration, and gratitude, which guide their approach to building and supporting companies. Human Ventures' portfolio includes innovative companies like Headspace, an app for meditation and sleep; Paloma Health, an online medical practice for hypothyroidism; and Tiny Organics, a nutrition company for early childhood. The firm also operates "Humans in the Wild," a program that fosters a community of entrepreneurs and provides resources to help them grow and succeed.

Humboldt Fund, founded in 2020 and based in New York, is a venture capital firm focused on investing in the biotech revolution. The fund specializes in early-stage investments in synthetic biology, targeting industries that are transforming the way chemicals, materials, foods, and medicines are made. Humboldt’s mission is to back pioneers in engineering, physical sciences, and life sciences, supporting groundbreaking technologies with the potential to disrupt global markets and solve critical challenges. Key areas of investment include foodtech, healthcare, energy, and advanced materials, with a strong emphasis on synthetic biology and bio-manufacturing. Notable portfolio companies include Metagenomi, Debut Biotech, and Finless Foods, all of which are at the forefront of biotechnological innovation. Humboldt aims to create both economic value and global impact by fostering these revolutionary technologies. Humboldt primarily invests in pre-seed, seed, and Series A stages, with a typical check size ranging from $4M to $36M. The fund is known for supporting companies that contribute to sustainability and technological advancements. By identifying and nurturing trailblazing companies, Humboldt Fund helps bring emerging biotech enterprises to global markets, positioning itself as a key player in the future of biotechnological innovation.

Hummingbird VC, founded in 2010 and based in Antwerp, Belgium, is an early-stage venture capital firm that invests globally, backing founders with groundbreaking ideas. The firm has a strong portfolio with notable investments in companies like Deliveroo, Kraken, and Peak Games. Hummingbird VC focuses on a wide array of industries including fintech, biotech, deep tech, healthcare, and marketplaces, with investments across North America, EMEA, and APAC regions. Hummingbird's investment strategy centers on partnering early with outlier founders and providing unwavering support through the company's lifecycle. They are known for their high conviction and willingness to make substantial investments, often leading funding rounds with check sizes ranging from $500K to over $50M. They prefer a low-friction partnership approach, allowing entrepreneurs to dictate the level of involvement and support needed. Key figures in the team include Barend Van den Brande, the founder, who is based in Belgium, and other partners spread across their international offices. Hummingbird is noted for its patient capital and long-term support, especially during challenging times for startups. They emphasize radical candor and dedication to the founders they back, aiming to foster transformative growth and industry disruption.

Hunniwell Lake Ventures is a Palo Alto-based venture capital firm founded in 2019, specializing in the healthcare sector, with a particular focus on medical devices. The firm targets early-stage companies that innovate in areas such as surgical robotics, electrosurgical technologies, and disease detection systems. Their investment strategy emphasizes reducing technology and regulatory risks by backing innovations that build upon proven technologies. The firm also leverages a global network of suppliers, distributors, and hospital partnerships to help startups scale rapidly and achieve market penetration. Hunniwell typically invests in startups with existing sales teams and distribution channels, aiming to accelerate their growth through strategic partnerships, especially in China, and by sharing infrastructure and expertise. Their portfolio includes notable companies like WaveClear Vascular and CoapTech. Key figures at Hunniwell include Richard Fang and Daniel Teo, both managing partners with extensive backgrounds in medical technology investments. They are supported by industry veterans like John Ashley, an Entrepreneur-in-Residence, who has a track record of leading multiple successful exits in the medtech space.

Huron River Ventures, founded in 2010 and based in Ann Arbor, Michigan, focuses on early-stage investments in agriculture, energy, and manufacturing technology. They primarily invest in the Midwest, supporting startups that offer innovative and sustainable solutions within these sectors. The firm typically invests $1-5 million per company across seed, Series A, and Series B stages. Notable investments include companies like Postmates, SkySpecs, and FarmLogs. Huron River Ventures has a strong track record, having made 50 investments and achieved 16 successful exits. The leadership team, including co-founders Ryan Waddington and Tim Streit, brings extensive experience in technology investments. The firm emphasizes supporting entrepreneurs with both capital and strategic guidance, leveraging their industry knowledge and networks to help startups grow and succeed.

HV Capital, formerly known as Holtzbrinck Ventures, is one of Europe’s most prominent venture capital firms, founded in 2000. With over €2.8 billion in assets under management, HV Capital has backed more than 225 startups, including major European success stories like Zalando, HelloFresh, SumUp, and Flixbus. The firm is known for its long-term commitment to founders, often supporting companies from seed stages through to growth and even exit phases. HV Capital recently launched its largest fund, Fund IX, at €710 million, aimed at startups across various stages from seed to Series D. The fund focuses on industries such as B2B software, consumer tech, healthcare, AI, and logistics. It also emphasizes sustainability, with a portion of the fund allocated to ESG-compliant companies and targets for female leadership across its portfolio. The firm’s investment approach combines financial backing with operational support, fostering an ecosystem where companies can thrive across Europe. HV Capital's team, based in Munich and Berlin, works closely with founders to help scale their businesses internationally.

Hyperplane Venture Capital, founded in 2014 and based in Boston, Massachusetts, focuses on early-stage investments in technology sectors like machine intelligence, AI, distributed systems, automation, cloud computing, and robotics. The firm has a robust portfolio of 112 investments, supporting innovative startups that leverage advanced technologies to solve complex problems. Notable investments include Modulate, Butlr, Flexpa, and LinkSquares. These companies span diverse industries, from AI and machine learning to health tech and enterprise software. Hyperplane has a strong track record with several successful exits, including Aryeo and RoadBotics, and continues to invest in cutting-edge technologies​. The team at Hyperplane includes experienced professionals like Brendan Kohler, John Murphy, and Vivjan Myrto, who bring a wealth of expertise in technology and venture capital. They provide strategic guidance and mentorship to their portfolio companies, helping them navigate growth challenges and scale effectively. Hyperplane's investments are primarily concentrated in the United States, but they also have a presence in other countries, including Canada and the United Kingdom. Their approach involves close collaboration with founders, aiming to drive innovation and create significant market impact through their strategic investments.

Hyphen Capital is a venture capital fund focused on supporting Asian American and Pacific Islander (AAPI) founders. Based in San Francisco, Hyphen Capital actively invests across various stages, with a significant presence in seed and early-stage funding rounds. The fund emphasizes sectors like fintech, enterprise applications, healthcare, and consumer products. Notable investments include Persona, an identity verification solutions provider valued at $1.5 billion, and Prime Roots, a producer of alternative protein products. Other key investments include Super, an online travel booking platform, and Poised, an AI-enabled communication assistant. Hyphen Capital's investment strategy centers on leveraging its strong network of AAPI entrepreneurs and executives, including prominent figures like Kevin Chou (Kabam), Ellen Chen (Mendocino Farms), and Patrick Lee (Rotten Tomatoes). The fund aims to back founders who are poised to disrupt their industries with innovative solutions and significant growth potential. Hyphen Capital tends to lead investment rounds, with typical check sizes ranging from $100,000 to $4.5 million. They prefer startups to approach them with a clear, scalable business model and a strong founding team. The fund has made 38 investments to date, with 3 successful exits. Led by Dave Lu, a well-respected figure in Silicon Valley, Hyphen Capital provides not just capital but also strategic guidance and access to a vast network of industry leaders, making it an invaluable partner for startups looking to scale rapidly. Hyphen Capital's approach is holistic, emphasizing long-term relationships and community support, reflecting their mission to empower the next generation of AAPI founders to achieve extraordinary success.

I2BF Global Ventures is an international technology-focused venture capital firm founded in 2005 and headquartered in New York, with additional offices in London, Los Angeles, Moscow, Dubai, and Astana, Kazakhstan. The firm manages over $400 million under management and is currently investing from its fifth fund. The team of 16 members includes 6 partners, 1 venture partner, and 3 principals spread across the UK, US, and additional international locations. I2BF's mission is to identify innovative companies targeting technologies and sectors capable of producing a 'Brighter Future.' I2BF leads rounds primarily at seed and Series A stages, having invested in approximately 141 companies with 6 new investments in the past 12 months. The portfolio spans cleantech, biotechnology, materials science, information technology, and space technology. The firm has produced three unicorns: Nothing (consumer electronics), Airalo (the eSIM marketplace that raised a $54 million Series A), and MoonPay (crypto payments). Notable IPO exits include ServiceTitan, which listed on NASDAQ in December 2024 at a $5.31 billion market cap, and FuboTV (sports streaming). The portfolio has also seen 19 acquisitions. I2BF has a global investment mandate covering the US, Europe, the Middle East, and Central Asia, reflecting its geographically distributed office footprint. The firm's longevity across five funds over two decades, combined with unicorn and public market exits across diverse technology sectors, positions I2BF as one of the more internationally oriented mid-sized venture capital firms operating out of New York.

IA Ventures, founded in 2010 and based in New York City, focuses on seed and early-stage investments, particularly in the fintech sector. The firm has made 184 investments and has seen 44 exits, showcasing its strong presence and success in the venture capital space. Notable companies in IA Ventures' portfolio include DigitalOcean, a cloud infrastructure provider; The Trade Desk, a global technology company for advertisers; and Datadog, a monitoring and security platform for cloud applications. Other significant investments are in companies like Octane, a fintech company for powersports financing, and YipitData, which provides data-driven research to institutional investors. IA Ventures invests across a variety of sectors including big data and analytics, cybersecurity, AI and machine learning, and SaaS. The firm is known for its hands-on approach, working closely with startups to help them grow and succeed in competitive markets. The team at IA Ventures includes experienced partners like Brad Gillespie and Jesse Beyroutey, who bring extensive expertise and support to their portfolio companies.

IBB Ventures is a prominent venture capital firm based in Berlin, specializing in early-stage investments. Since 1997, it has played a key role in fostering the growth of innovative startups, particularly those based in the Berlin region. With a focus on sectors like software, healthcare, industrial technologies, and creative industries, IBB Ventures supports scalable, disruptive business models that drive innovation. Their investment funds are primarily backed by the Investitionsbank Berlin and the European Regional Development Fund. The firm manages several VC funds, including the VC Fonds Technologie III and the VC Fonds Kreativwirtschaft III, with a total volume of €120 million. In 2022, IBB Ventures introduced an additional €30 million Impact VC Fund to support startups focused on ecological, social, and sustainable goals. Typically, they provide seed and Series A financing, working closely with portfolio companies to achieve sustainable growth and mid-term exits, often through trade sales or IPOs. IBB Ventures has invested in over 260 companies and continues to be a significant player in Berlin's startup ecosystem.

Ibex Investors, established in 2003 and headquartered in Denver, Colorado, is a venture capital firm that invests across various stages of a company's lifecycle, from seed to IPO and beyond. The firm focuses on geographic regions, particularly Israel, and thematic areas such as mobility. Ibex has made notable investments in companies like WEKA, Honeycomb Insurance, and Chemix, demonstrating a strong presence in sectors like IT consulting, property and casualty insurance, and business productivity software. The firm has completed 82 investments and achieved 22 exits, including prominent companies like Cynet, Cobwebs Technologies, and Zimperium. Led by founder and CEO Justin Borus, Ibex Investors aims to provide a world-class experience and value-added support to its portfolio companies, emphasizing a proactive search for overlooked market opportunities. The team includes key partners such as Aaron Rinberg and Gal Gitter, who focus on Israeli investments, highlighting the firm’s strong ties to the Israeli tech ecosystem.

IBM is a global leader in technology, known for its advancements in hybrid cloud solutions, artificial intelligence (AI), and consulting services. The company operates in over 175 countries, serving industries like finance, healthcare, and telecommunications by helping organizations transform their digital infrastructures. One of its key innovations includes the IBM Watson AI platform, which powers everything from generative AI in business to sports analytics, like enhancing ESPN’s fantasy football platform. IBM is also a pioneer in quantum computing and semiconductors, consistently pushing the boundaries of modern technology with breakthroughs like the world’s first 2-nanometer chip in 2021. Their hybrid cloud ecosystem, supported by Red Hat OpenShift, provides companies with flexible and scalable solutions for managing critical operations efficiently and securely. In addition to its technological leadership, IBM is heavily invested in social impact, with initiatives like the IBM SkillsBuild program, offering free training in tech skills to underserved communities. The company is also committed to achieving net-zero carbon emissions by 2030, integrating sustainability into its business operations globally.

Icebreaker.vc, established in 2016 and based in Helsinki, focuses on early-stage investments, particularly in Finland, Sweden, and Estonia. They target pre-seed and seed-stage companies with investments ranging from €150,000 to €800,000. Icebreaker.vc's portfolio includes notable companies such as Valpas, Lumoa, Workfellow, and Oterlu. Icebreaker.vc supports teams with deep domain expertise and a vision for global impact, spanning various sectors like fintech, healthcare, consumer goods, and energy. They emphasize strong, complementary founding teams and provide extensive support through their community of over 1,000 experienced professionals. The firm has raised significant funds to continue backing innovative startups, including a recent €120 million fund to further invest in and support their portfolio companies from the earliest stages. Key team members include Lasse Lehtinen, Aleksi Partanen, and Riku Seppälä, all of whom bring extensive experience in founding and scaling tech companies. Their approach combines capital with strategic operational support to help startups navigate growth challenges and achieve market success.

ICONIQ Capital, a multifaceted investment management firm headquartered in San Francisco, manages over $80 billion in assets. The firm is known for serving influential families and organizations, particularly those in technology, high finance, and entertainment sectors. ICONIQ has a robust portfolio featuring investments in prominent tech companies. Notable portfolio companies include Airbnb, Alibaba, Facebook, Snowflake, and Uber. They also have significant stakes in innovative firms like OpenAI, HashiCorp, and Miro, showcasing their focus on transformative technologies and scalable business models. Their investment strategy involves partnering with inspired entrepreneurs to drive industry transformation. ICONIQ Capital provides not only financial support but also strategic guidance, leveraging their extensive network to foster growth and innovation. The firm operates globally with offices in New York, London, and Hong Kong, offering a comprehensive range of services including private equity, venture capital, real estate, and philanthropic advisory. ICONIQ's team comprises experienced professionals like Divesh Makan, one of the founders, who bring deep expertise and a hands-on approach to managing investments and advising clients.

Icos Capital is a Dutch venture capital firm specializing in ClimateTech investments, focusing on sectors such as food systems, decarbonization, sustainable chemicals, and materials. Since its founding in 2005, Icos Capital has been committed to supporting early-growth stage companies that drive sustainability and industrial decarbonization. The firm is known for its Collaborative Venturing Platform (CVP), which connects startups with leading corporations, providing not only capital but also engineering expertise, market access, and production infrastructure. With a goal to reduce or avoid 1 gigaton of CO2 emissions by 2050, Icos Capital takes a hands-on approach to investing, helping innovative startups scale quickly while ensuring measurable environmental impact. Some of its successful portfolio companies include Carbon Clean, eAgronom, and Holiferm, each making strides in carbon capture, regenerative agriculture, and sustainable product developmen. Icos Capital continues to manage multiple funds, the latest being Icos IV, with a targeted size of €100 million, designed to accelerate sustainability across industries. The firm primarily focuses on European companies but also supports those in the U.S. and Asia with strong ties to the European market.

Idinvest Partners, founded in 1997 and headquartered in Paris, France, is a leading European private equity and venture capital firm. The firm specializes in low and middle-market segments, investing across various stages, including early-stage, growth-stage, and later-stage companies. Idinvest Partners is particularly active in the IT, healthcare, and financial services sectors, and has made notable investments in companies such as Deezer, Criteo, Dailymotion, and Sigfox​. In 2018, Idinvest Partners was acquired by Eurazeo, creating a combined entity with over $15 billion in assets under management. This acquisition has bolstered Idinvest’s capacity to support innovative startups and expand its reach globally​. The firm has a diversified investment strategy, leveraging its expertise in venture and growth capital, private debt, and private equity to drive growth and value creation in its portfolio companies. Idinvest Partners operates with a strong presence in Europe and has extended its investments to the United States and Asia. Recent investments include companies like Dark (aerospace and defense) and Cove (real estate services), highlighting its broad investment approach across different sectors​.

IDIA Capital Investissement is a venture capital and private equity firm based in Montrouge, France. It operates as the investment arm of the Crédit Agricole Group, focusing on minority equity investments to support the growth and development of mid-sized companies (ETIs) and small to medium-sized enterprises (SMEs). Established over 30 years ago, IDIA specializes in sectors such as agribusiness, viticulture, healthcare, tourism, and energy transition​. The firm manages a substantial portfolio with assets under management totaling €2.2 billion. They typically invest between €1 million and €50 million per transaction, leveraging the extensive Crédit Agricole network to provide strategic and financial support to their portfolio companies. IDIA Capital Investissement is committed to responsible investing, emphasizing environmental, social, and governance (ESG) criteria in their decision-making process. This approach aligns with Crédit Agricole's broader mission of promoting sustainable finance and supporting projects that address key societal and environmental challenges​.

iGan Partners is a leading venture capital firm based in Toronto, Canada, specializing in early-stage investments in technology and healthcare sectors. Founded in 1999, iGan Partners has built a strong portfolio by partnering with innovative startups and helping them scale their disruptive technologies. The firm has a diverse portfolio that includes companies like Think Research, a provider of clinical content and technology solutions; MolecuLight, which develops imaging devices for wound care; and eSight, known for creating electronic glasses that improve vision for the legally blind. Other notable investments include MedChart, a platform that enables businesses to access and exchange patient-authorized digital health information, and Cosm Medical, which designs medical devices for personalized pelvic health solutions. iGan Partners typically invests in seed and Series A rounds, with a focus on companies in the healthcare sector, including medical devices, digital health, and health IT. They have been involved in funding rounds for companies like Hyivy Health and Curv Health, supporting innovative solutions in personal health and wellness. The firm is led by a team of experienced professionals, including Founder and Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora. Their extensive expertise in healthcare and technology enables them to provide valuable support and strategic guidance to their portfolio companies​.

iGlobe Partners, founded in 1999 and headquartered in Singapore, is a prominent venture capital firm with a global investment strategy. The firm focuses on early to growth-stage investments in tech-driven sectors such as smart cities, synthetic biology, and fintech. iGlobe Partners has a strong track record of investing in transformative companies and has managed funds exceeding USD 500 million​. Their diverse portfolio includes notable companies such as Matterport, which provides AI-powered 3D data platforms to create digital twins of physical spaces, and NerdWallet, a popular personal finance company. Additionally, they have invested in C2i Genomics, a leader in cloud-based cancer diagnostics, and Twist Bioscience, which is revolutionizing DNA synthesis. iGlobe Partners' investment approach emphasizes collaboration with top-tier scientific and entrepreneurial talent to drive innovation. The firm has been instrumental in scaling game-changing companies across the U.S., Europe, and Asia, leveraging its extensive global network to support portfolio companies in expanding their market reach​. With the recent close of their USD 100 million iGlobe Platinum Fund III, the firm continues to invest in high-growth areas, particularly focusing on innovations in healthcare, logistics, and smart city technologies. This strategic focus aims to capitalize on the accelerated adoption of technology driven by the COVID-19 pandemic, promising substantial returns in the long term.

Illinois Ventures is a venture capital firm dedicated to investing in early-stage technology and healthcare companies. Based in Champaign, Illinois, and closely affiliated with the University of Illinois System, the firm focuses on translating innovative research into impactful businesses. Illinois Ventures has a robust portfolio that includes companies like Ocient, a big data analytics company, and EarthSense, a developer of autonomous robots for agriculture. Their investments span various sectors including biotechnology, healthcare IT, clean energy, and advanced manufacturing technologies. The firm primarily invests at the seed and Series A stages, leveraging its strong connections with the University of Illinois to gain early access to groundbreaking technologies. This relationship allows Illinois Ventures to support startups with both capital and strategic guidance, fostering growth from the ground up. The leadership team includes Nancy Sullivan, the CEO and Managing Director, and other experienced professionals like Thomas Parkinson and Nancy Harvey. They bring a wealth of experience in venture capital, business development, and operations, providing comprehensive support to their portfolio companies.